Opiant Pharmaceuticals to Participate in September Investor Conferences
Opiant Pharmaceuticals (Nasdaq: OPNT) announced its participation in several virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals (Nasdaq: OPNT) announced its participation in several virtual investor conferences. The H.C. Wainwright 23rd Annual Global Investment Conference will take place from September 13-15, 2021, featuring an on-demand presentation available at 7:00am ET on September 13. The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit follows on September 20-23, 2021, with a presentation scheduled for September 20 at 4:35 pm ET. Lastly, the Cantor 2021 Virtual Global Healthcare Conference will occur on September 27-30, 2021, including a fireside chat on September 29 at 4:00 pm ET.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was +13.76%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today announced that members of the company’s senior management team will participate in the following virtual investor conferences:
- H.C. Wainwright 23rd Annual Global Investment Conference
September 13-15, 2021
On-demand presentation will be available at 7:00am ET on September 13; hosting 1-on-1 meetings - Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 20-23, 2021
Presentation on September 20 at 4:35 pm ET; hosting 1-on-1 meetings
- Cantor 2021 Virtual Global Healthcare Conference
September 27-30, 2021
Fireside chat on September 29 at 4:00 pm ET; hosting 1-on-1 meetings
A webcast of each presentation and fireside chat will be accessible on the Opiant website.
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.